25 April 2020 I was asked to help the UCLA Jonsson Comprehensive Cancer Center team develop some infographics to help answer some common questions that patients with cancer may have regarding their treatment, office visits, and risk of infection. As always, good communication with your medical team is important – so reach out and ask […]

24 April 2020 A new drug was recently approved by the US Food and Drug Administration (FDA) for the treatment of metastatic breast cancer – breast cancer that has spread to other areas of the body, such as the bones, liver, lungs or brain. Sacituzumab govitecan (Trodelvy), which is given by intravenous infusion, was granted accelerated approval to […]

19 April 2020 The US Food and Drug Administration (FDA) has recently approved a new treatment for patients with metastatic breast cancer. Tucatinib (Tukysa) was approved for use in combination with 2 other agents, trastuzumab (Herceptin) and capecitabine (Xeloda) in patients with unresectable (too advanced to remove with surgery) or metastatic (spread to other areas of the […]

07 April 2020 Many of us are struggling to adjust to the changes we have had to make due to the COVID-19 (coronavirus disease 2019) pandemic. For those newly diagnosed with or undergoing treatment for cancer, there is an added level of anxiety and uncertainty, especially as national medical societies have made recommendations to curtail […]

15 March 2020 Ductal carcinoma in-situ, also known as DCIS or stage 0 breast cancer, is traditionally treated with surgical excision (lumpectomy or mastectomy). Treatment may also include radiation therapy, as well as endocrine therapy (tamoxifen or an aromatase inhibitor) if the disease is estrogen receptor positive (ER+). For invasive cancer, we sometimes take a neoadjuvant approach, treating […]

18 February 2020 The American Society of Clinical Oncology recently published a guideline for the management of male breast cancer* (and I was proud to serve on the guideline consensus panel). Breast cancer in men accounts for approximately 1% of all breast cancer cases. Outcomes are known to be worse compared with those in women, […]

10 February 2020 Our publication “Proposing a Bill of Rights for Patients with Cancer” was just published! Many thanks to my co-authors, and to all of the patients who inspired this piece.